Par Biosciences Private Limited - Company Profile

Q: Where is Par Biosciences Private Limited headquartered?

Par Biosciences Private Limited is headquartered at 9215 Pudupakkam Vandalur Main Road Pudupakkam, Kelambakkam, Chennai, Tamil Nadu, 603103.

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2012.

2012 Chennai, Tamil Nadu, India Active

Last Updated: January 01, 2026

Access Report

About Par Biosciences Private Limited

Par Biosciences Private Limited, a active private limited company, was established on 15 June 2012 in Chennai, Tamil Nadu, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24233TN2012PTC086326. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.01 Cr and a paid-up capital of ₹5.71 Cr.

Formerly known as Ethics Bio Lab Private Limited. It upholds a compliant status. Employing 39 professional, Its leadership includes James Matthew Papp (Director), Chitti Babu Sampath Kumar (Director), Anand Amrit Raj (Director). Past directors included Ayyavu Rajavel, Rahul Garella, Paul Victor Campanelli. It holds no open charges and ₹10.89 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 9/215 Pudupakkam Vandalur Main Road Pudupakkam, Kelambakkam, Chennai, Tamil Nadu, 603103.

Company Details

CIN/LLPIN
U24233TN2012PTC086326
Registration Number
086326
Incorporation Date
15 June 2012
Authorized Capital
₹6.01 Cr
Paid-Up Capital
₹5.71 Cr
ROC Code
Roc Chennai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 6.01 Cr as on 01-01-2026
Paid Up Capital ₹ 5.71 Cr as on 01-01-2026
Company Age 13 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 10.89 Cr as on 01-01-2026
Revenue Growth **** -55.63% (FY 2023)
Profit Growth **** -12.56% (FY 2023)
Ebitda **** -64.44% (FY 2023)
Net Worth 10.45% (FY 2023)
Total Assets -17.10% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Par Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Par Biosciences Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
James Matthew Papp	Director	28 Jan 2021	Current
Chitti Babu Sampath Kumar	Director	28 Jun 2017	Current
Anand Amrit Raj	Director	27 May 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	15 Jan 2015	Past
Pramod Abcsdd	Additional Director	16 Aug 2018	Past
Pramod Abcsdd	Director	25 Sep 2015	Past
Pramod Abcsdd	Additional Director	15 Sep 2016	Past
Pramod Abcsdd	Additional Director	29 Nov 2021	Past
Pramod Abcsdd	Director	27 May 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Par Biosciences.

Par Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 55.63% decrease. The company also saw a substantial fall in profitability, with a 12.56% decrease in profit. The company's net worth Soared by an impressive increase of 10.45%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-55.63%

*******

Revenue from Operations

*******

-62.54%

*******

Total Assets

*******

-17.10%

*******

Profit or Loss

*******

-12.56%

*******

Net Worth

*******

10.45%

*******

EBITDA

*******

-64.44%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Par Biosciences?

In 2023, Par Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹108,900,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 10.64 Cr
Others : 0.25 Cr

Latest Charge Details

Date	Lender	Amount	Status
08 Aug 2022	Others	₹2.50 M	Satisfied
19 Dec 2012	State Bank Of India	₹10.64 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Par Biosciences?

Par Biosciences has a workforce of 39 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Par Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Par Biosciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Par Biosciences

Recent Activity within the Organization

Annual General Meeting

The activity Par Biosciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
29 Sep 2025
Balance Sheet

Progress on Par Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.
31 Mar 2025
Charges

A charge registered on 08 Aug 2022 via Charge ID 100611330 with Others was fully satisfied on 20 Feb 2023. was recorded as a recent event.
20 Feb 2023
Charges

Progress on A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100611330 was registered on 08 Aug 2022. was documented.
08 Aug 2022
Director Appointment

Progress on Anand Amrit Raj was appointed as a Director was appointed as a Director on 27 May 2022 & has been associated with this company since 3 years 8 months . was documented.
27 May 2022
Director Appointment

Progress on James Matthew Papp was appointed as a Director was appointed as a Director on 28 Jan 2021 & has been associated with this company since 5 years 13 days . was documented.
28 Jan 2021

Explore recent activity and updates - View Recent Activity